240 related articles for article (PubMed ID: 23263025)
1. Newer antifungal agents.
Larru B; Zaoutis TE
Curr Opin Pediatr; 2013 Feb; 25(1):110-5. PubMed ID: 23263025
[TBL] [Abstract][Full Text] [Related]
2. New antifungal agents in pediatric practice.
Das S; Shivaprakash MR; Chakrabarti A
Indian Pediatr; 2009 Mar; 46(3):225-31. PubMed ID: 19346570
[TBL] [Abstract][Full Text] [Related]
3. The value of amphotericin B in the treatment of invasive fungal infections.
Klepser M
J Crit Care; 2011 Apr; 26(2):225.e1-10. PubMed ID: 20951541
[TBL] [Abstract][Full Text] [Related]
4. Antifungal treatment in pediatric patients.
Zaoutis TE; Benjamin DK; Steinbach WJ
Drug Resist Updat; 2005 Aug; 8(4):235-45. PubMed ID: 16054422
[TBL] [Abstract][Full Text] [Related]
5. The current role of amphotericin B lipid complex in managing systemic fungal infections.
Chu P; Sadullah S
Curr Med Res Opin; 2009 Dec; 25(12):3011-20. PubMed ID: 19849324
[TBL] [Abstract][Full Text] [Related]
6. Clinical indications for newer antifungal agents.
Naeger-Murphy N; Pile JC
J Hosp Med; 2009 Feb; 4(2):102-11. PubMed ID: 19219926
[TBL] [Abstract][Full Text] [Related]
7. Antifungal prophylaxis and therapy in patients with hematological malignancies and hematopoietic stem cell transplant recipients.
Almyroudis NG; Segal BH
Expert Rev Anti Infect Ther; 2010 Dec; 8(12):1451-66. PubMed ID: 21133669
[TBL] [Abstract][Full Text] [Related]
8. Management of invasive fungal infections: a role for polyenes.
Chandrasekar P
J Antimicrob Chemother; 2011 Mar; 66(3):457-65. PubMed ID: 21172787
[TBL] [Abstract][Full Text] [Related]
9. Recent approaches to antifungal therapy for invasive mycoses.
Mathew BP; Nath M
ChemMedChem; 2009 Mar; 4(3):310-23. PubMed ID: 19170067
[TBL] [Abstract][Full Text] [Related]
10. [Antifungal agents in the treatment of systemic infections: Relevance of mechanism of action, activity profile and resistances].
Cuenca-Estrella M
Rev Esp Quimioter; 2010 Dec; 23(4):169-76. PubMed ID: 21191554
[TBL] [Abstract][Full Text] [Related]
11. New triazoles and echinocandins: mode of action, in vitro activity and mechanisms of resistance.
Fera MT; La Camera E; De Sarro A
Expert Rev Anti Infect Ther; 2009 Oct; 7(8):981-98. PubMed ID: 19803707
[TBL] [Abstract][Full Text] [Related]
12. [Fungal infections in children with malignant disease].
Michel G
Arch Pediatr; 2011 May; 18 Suppl 1():S3-7. PubMed ID: 21596284
[TBL] [Abstract][Full Text] [Related]
13. Antifungal chemotherapeutics.
Krcmery VC
Med Princ Pract; 2005; 14(3):125-35. PubMed ID: 15863983
[TBL] [Abstract][Full Text] [Related]
14. Improved outcomes associated with advances in therapy for invasive fungal infections in immunocompromised hosts.
Metcalf SC; Dockrell DH
J Infect; 2007 Oct; 55(4):287-99. PubMed ID: 17697716
[TBL] [Abstract][Full Text] [Related]
15. Newer antifungal agents for invasive fungal infections in patients with haematological malignancy.
Rogers TR; Frost S
Br J Haematol; 2009 Mar; 144(5):629-41. PubMed ID: 19120371
[TBL] [Abstract][Full Text] [Related]
16. [Pharmacokinetics and pharmacodynamics of antifungal drugs in children].
Jullien V
Arch Pediatr; 2011 May; 18 Suppl 1():S42-7. PubMed ID: 21596286
[TBL] [Abstract][Full Text] [Related]
17. [Antimycotic therapy].
Schaffner A
Ther Umsch; 1990 Aug; 47(8):664-9. PubMed ID: 2218968
[TBL] [Abstract][Full Text] [Related]
18. Antifungal drugs.
Treat Guidel Med Lett; 2008 Jan; 6(65):1-8. PubMed ID: 18157085
[No Abstract] [Full Text] [Related]
19. Overview of treatment options for invasive fungal infections.
Pound MW; Townsend ML; Dimondi V; Wilson D; Drew RH
Med Mycol; 2011 Aug; 49(6):561-80. PubMed ID: 21366509
[TBL] [Abstract][Full Text] [Related]
20. Anidulafungin and voriconazole in invasive fungal disease: pharmacological data and their use in combination.
Perkhofer S; Lass-Flörl C
Expert Opin Investig Drugs; 2009 Sep; 18(9):1393-404. PubMed ID: 19656074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
